Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

被引:2
作者
Szabo, Agoston Gyula [1 ]
Klausen, Tobias Wirenfeldt [2 ]
Abildgaard, Niels [3 ]
Gregersen, Henrik [4 ]
Silkjaer, Trine [5 ]
Pedersen, Per Trollund [6 ]
Pedersen, Robert Schou [7 ]
Helleberg, Carsten [2 ]
Hermansen, Emil [8 ]
Schnack, Brian Iversen [1 ]
Vangsted, Annette Juul [9 ]
机构
[1] Vejle Hosp, Dept Hematol, Vejle, Denmark
[2] Herlev Univ Hosp, Dept Hematol, Herlev, Denmark
[3] Odense Univ Hosp, Dept Hematol, Odense, Denmark
[4] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark
[5] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
[6] Esbjerg Cent Hosp, Dept Hematol, Esbjerg, Denmark
[7] Regionshosp Holstebro, Dept Hematol, Holstebro, Denmark
[8] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
[9] Rigshosp, Dept Hematol, Copenhagen, Denmark
关键词
TERM-FOLLOW-UP; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; PROGRESSION; MORTALITY; IMPACT;
D O I
10.1038/s41408-021-00460-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 15 条
[1]  
Abildgaard N, 2015, CLIN LYMPHOMA MYELOM, V15, pe189
[2]   A population-based study of the impact of dialysis on mortality in multiple myeloma [J].
Evison, Felicity ;
Sangha, Jason ;
Yadav, Punit ;
Aung, Yu Sandar ;
Sharif, Adnan ;
Pinney, Jennifer A. ;
Drayson, Mark T. ;
Cook, Mark ;
Cockwell, Paul .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (04) :588-591
[3]   The Danish National Multiple Myeloma Registry [J].
Gimsing, Peter ;
Holmstrom, Morten O. ;
Klausen, Tobias Wirenfelt ;
Andersen, Niels Frost ;
Gregersen, Henrik ;
Pedersen, Robert Schou ;
Plesner, Torben ;
Pedersen, Per Trollund ;
Frederiksen, Mikael ;
Frolund, Ulf ;
Helleberg, Carsten ;
Vangsted, Annette ;
Brown, Peter de Nully ;
Abildgaard, Niels .
CLINICAL EPIDEMIOLOGY, 2016, 8 :583-587
[4]   The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study [J].
Gregersen, Henrik ;
Vangsted, Annette Juul ;
Abildgaard, Niels ;
Andersen, Niels Frost ;
Pedersen, Robert Schou ;
Frolund, Ulf Christian ;
Helleberg, Carsten ;
Broch, Bettina ;
Pedersen, Per Trollund ;
Gimsing, Peter ;
Klausen, Tobias Wirenfeldt .
CANCER MEDICINE, 2017, 6 (07) :1807-1816
[5]   Bone Disease in Multiple Myeloma: Pathophysiology and Management [J].
Hameed, Abdul ;
Brady, Jennifer J. ;
Dowling, Paul ;
Clynes, Martin ;
O'Gorman, Peter .
CANCER GROWTH AND METASTASIS, 2014, 7 :33-42
[6]   Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database [J].
Holmstrom, Morten O. ;
Gimsing, Peter ;
Abildgaard, Niels ;
Andersen, Niels F. ;
Helleberg, Carsten ;
Clausen, Niels Aage T. ;
Klausen, Tobias W. ;
Frederiksen, Mikael ;
Kristensen, Dan L. ;
Larsen, Herdis ;
Pedersen, Per T. ;
Andersen, Kristian Thidemann ;
Pedersen, Robert Schou ;
Jensen, Bo Amdi ;
Gregersen, Henrik ;
Vangsted, Annette J. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (04) :E73-E74
[7]   Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management [J].
Kyle, R. A. ;
Durie, B. G. M. ;
Rajkumar, S. V. ;
Landgren, O. ;
Blade, J. ;
Merlini, G. ;
Kroeger, N. ;
Einsele, H. ;
Vesole, D. H. ;
Dimopoulos, M. ;
San Miguel, J. ;
Avet-Loiseau, H. ;
Hajek, R. ;
Chen, W. M. ;
Anderson, K. C. ;
Ludwig, H. ;
Sonneveld, P. ;
Pavlovsky, S. ;
Palumbo, A. ;
Richardson, P. G. ;
Barlogie, B. ;
Greipp, P. ;
Vescio, R. ;
Turesson, I. ;
Westin, J. ;
Boccadoro, M. .
LEUKEMIA, 2010, 24 (06) :1121-1127
[8]   Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance [J].
Kyle, Robert A. ;
Larson, Dirk R. ;
Therneau, Terry M. ;
Dispenzieri, Angela ;
Kumar, Shaji ;
Cerhan, James R. ;
Rajkumar, S. Vincent .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (03) :241-249
[9]   Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Giraldo, Pilar ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Arguinano, Jose-Maria ;
Quintana, Nuria ;
Garcia, Jose-Luis ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San Miguel, Jesus-F .
LANCET ONCOLOGY, 2016, 17 (08) :1127-1136
[10]  
Rajkumar S Vincent, 2016, Am Soc Clin Oncol Educ Book, V35, pe418, DOI 10.14694/EDBK_159009